Skip to content
Saturday, 24 October 2026RSS
APAC Capital Brief

Institution record

Market Equity

Market Equity INC

Risk level not supplied1 of 2 licences marked regulated
Source score
5.0
Warnings
0
Comments
0

Licence records

Licences within our coverage (institutions licensed across asia-pacific and the middle east) are listed first. Check each one on the regulator's own register.

RegulatorLicence no.StatusLicensed entityDate
In our coverage
Labuan Financial Services Authority
MB/21/0083Suspected cloneMarket Equity Limited—
VFSC
Vanuatu Financial Services Commission
40221RegulatedMARKET EQUITY INC2022-12-30

Peer regulatory & risk comparison

Side-by-side supervisory and risk benchmark comparing Market Equity against peer institutions in our institutions licensed across asia-pacific and the middle east dataset.

Full directory →
InstitutionPrimary regulatorsRegulated / totalRisk classificationSource scoreWarnings
Market Equity (this record)
Labuan FSAVFSC
1 / 2Risk level not supplied5.00
Blueberry Markets
ASICASICASIC+1
3 / 4Risk level not supplied6.00
TMGM
FMAASICVFSC
2 / 3Risk level not supplied8.01
ICM
FSRALabuan FSAFSCA+1
3 / 4Risk level not supplied7.00
AIMS
Labuan FSAASIC
1 / 2Risk level not supplied7.00
FXTRADING
ASICASICVFSC
2 / 3Risk level not supplied6.00

Market Equity: institutional due diligence FAQ

Key supervisory, licensing, and counterparty verification questions generated from the dataset.

What is Market Equity's regulatory licence status and supervisory authorisation?

In our imported dataset, Market Equity (legal entity reference: Market Equity INC) holds 2 recorded licence entries, of which 1 carries a "regulated" status and 1 are marked regulated or registered: Labuan FSA (Labuan Financial Services Authority) — licence MB/21/0083, status: suspected clone; VFSC (Vanuatu Financial Services Commission) — licence 40221, status: regulated. Institutional due diligence requires verifying that the exact legal entity on your counterparty agreement matches the licensed entity name and registration number on the official Labuan FSA, VFSC public register.

Which of Market Equity's jurisdictions and licences fall within this site's regulatory coverage?

This directory focuses on institutions licensed across asia-pacific and the middle east. 1 of Market Equity's 2 licence records fall directly within this jurisdictional mandate: Labuan FSA (licence MB/21/0083, suspected clone, entity: Market Equity Limited). Always confirm whether client money segregation and statutory investor compensation schemes apply to the specific subsidiary onboarding your account.

What is Market Equity's institutional risk classification, enforcement exposure, and score profile?

Market Equity carries a "risk level not supplied" classification in the source dataset, alongside composite 5-dimension ratings out of 10 (overall: 5.0, risk & licensing: 5.0, brand: 5.0, market influence: 5.0, user reputation: 0.0). The record flags 0 regulatory warning or complaint counts and 1 licence record with elevated status flags (Labuan FSA: suspected clone). Because these figures reflect imported source fields rather than primary audit findings, compliance teams should review primary enforcement bulletins directly.

What operational due diligence steps apply to Market Equity's platforms, entity structure, and complaints?

Before allocating capital or executing trades with Market Equity, institutional and retail allocators should: (1) confirm the domain (not supplied in source) against regulator-approved domains to guard against clone firms; (2) verify whether any of the 0 recorded warning/complaint entries or 0 user comments involve withdrawal restrictions or scope violations; and (3) confirm the dispute-resolution ombudsman tied to Labuan FSA.

Editorial briefings and compliance research from APAC Capital Brief relevant to Market Equity's supervisory scope.

All research →

Asia

KOSPI closes at 5,550.30 after opening 2.36% lower

Seoul has a real close. Yonhap reported the KOSPI up 0.3% at 5,550.30, Samsung Electronics up 0.47% and SK hynix up 4.42%, after the index opened 2.36% lower.

Read briefing →

APAC Equities, Semiconductors & Cross-Border Capital Flows

APAC Equities & Semiconductor Capex Repricing (October 2026): Nikkei 225 Breaches 200-Day Moving Average, KOSPI -1.7% HBM Unwind, and USD/JPY Sub-156.68 Earnings Compression

An institutional Asia-Pacific quantitative dispatch dissecting the October 23, 2026 Nikkei 225 -1.3% breakdown below its 200-day moving average, USD/JPY breaching 156.68 exporter budget thresholds, South Korea's KOSPI -1.7% HBM memory unwind, and Brent crude's surge past $114/bbl driving capital rotation into Singapore SGX REITs and banks.

Read briefing →

APAC Regulatory & Capital Corridors

APAC Institutional Capital Corridors in 2026: Comparative Licensing, Capital Adequacy, and Cross-Border Settlement Across MAS, HKMA/SFC, JFSA, ASIC, and India GIFT City IFSCA

An institutional Asia-Pacific dispatch analyzing statutory licensing thresholds, base capital and liquid capital mandates, client money trust segregation, and digital-asset/derivatives execution corridors across Singapore (MAS), Hong Kong (SFC/HKMA), Japan (JFSA), Australia (ASIC), and India GIFT City (IFSCA).

Read briefing →

APAC Macro & Institutional Capital Markets

HKEX Swap Connect & Northbound Bond Connect Hedging, Nippon NISA Equity Flows & APAC Sovereign Wealth Allocation (2026 Briefing)

HKEX Swap Connect refers to the mutual interest rate derivatives clearing link between Hong Kong and mainland China, clearing ¥31.8 billion in daily notional volume [¥31.8 billion, HKEX, Q3 2026] alongside record Nippon NISA and Singapore sovereign allocations.

Read briefing →
Market Equity — Regulation, Licence Records & Risk Profile | APAC Capital Brief